Expression and clinical significance of antigen presentation components beta-2 microglobulin, HLA class I heavy chains, and HLA class II in non-small cell lung cancer (NSCLC).

被引：1
|
作者：
Datar, Ila
Villarroel-Espindola, Franz
Henick, Brian S.
Syrigos, Konstantinos N.
Toki, Maria
Rimm, David L.
Ferrone, Soldano
Herbst, Roy S.
Schalper, Kurt A.
机构：
[1] Yale Sch Med, New Haven, CT USA
[2] Natl & Kapodistrian Univ Athens, Sch Med, Athens, Greece
[3] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.12015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
12015
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Class II HLA-DRB4 is a predictive biomarker for survival following immunotherapy in metastatic non-small cell lung cancer
    Cindy Y. Jiang
    Lili Zhao
    Michael D. Green
    Shashidhar Ravishankar
    Andrea M. H. Towlerton
    Anthony J. Scott
    Malini Raghavan
    Matthew F. Cusick
    Edus H. Warren
    Nithya Ramnath
    Scientific Reports, 14
  • [42] Prognostic Value of HLA-A2 Status in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
    Mezquita, Laura
    Charrier, Melinda
    Faivre, Laura
    Remon, Jordi
    Planchard, David
    Bluthgen, Maria
    Dupraz, Louise
    Facchinetti, Francesco
    Lahmar, Jihene
    Gazzah, Annas
    Soria, Jean -Charles
    Pignon, Jean Pierre
    Chaput, Nathalie
    Besse, Benjamin
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S965 - S966
  • [43] HLA-A2 and immune checkpoints inhibitors in advanced non-small cell lung cancer (NSCLC) patients
    Mezquita, L.
    Charrier, M.
    Lahmar, J.
    Remon, J.
    Bluthgen, M. V.
    Facchinetti, F.
    Planchard, D.
    Gazzah, A.
    Dupraz, L.
    Adam, J.
    Chaput, N.
    Besse, B.
    ANNALS OF ONCOLOGY, 2016, 27
  • [44] EXPRESSION AND METHYLATION PATTERNS OF CLASS-I MHC GENES IN SMALL-CELL LUNG-CANCER (SCLC) AND NON-SMALL CELL LUNG-CANCER (NSCLC)
    HUSSAIN, A
    YEN, R
    BORGES, M
    AISNER, J
    DOYLE, A
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 349 - 349
  • [45] Expression of CD74 and class II major histocompatibility complex antigen (HLA-DR) in non small cell lung cancers (NSCLC) and associated alveolar cell hyperplasia (ACH).
    Rao, SK
    Woda, BA
    Savas, LM
    Fraire, AE
    LABORATORY INVESTIGATION, 1997, 76 (01) : 1002 - 1002
  • [46] Human leukocyte antigen (HLA) B44 supertype and immunotherapy outcomes in non-small cell lung cancer (NSCLC).
    Lu, Henry
    Cummings, Amy Lauren
    Goldman, Jonathan Wade
    Lisberg, Aaron Elliott
    Hu-Lieskovan, Siwen
    Grogan, Tristan
    Gukasyan, Jaklin
    Madrigal, John
    Carroll, James M.
    Bornazyan, Krikor
    Jones, Benjamin
    Noor, Zorawar Singh
    Zaretsky, Jesse Meir
    Elashoff, David
    Slamon, Dennis J.
    Dubinett, Steven M.
    Garon, Edward B.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [47] Class II and class III BRAF mutations in patients with advanced non-small cell lung cancer (NSCLC): Clinical characteristics, mutation patterns, and survival outcomes
    Rasokat, Anna
    Kron, Anna
    Nogova, Lucia
    Siebolts, Udo
    Scharpenseel, Heather
    Riedel, Richard
    Michels, Sebastian Yves Friedrich
    Fischer, Rieke Nila
    Eisert, Anna
    Prang, Darinka
    Beckers, Frank
    Kambartel, Kato
    Kaminsky, Britta
    Schaaf, Bernhard
    Schulte, Wolfgang
    Serke, Monika Heidi
    Merkelbach-Bruse, Sabine
    Buettner, Reinhard
    Wolf, Juergen
    Scheffler, Matthias
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [48] Correlations between class I glucose transporter expression patterns and clinical outcomes in non-small cell lung cancer
    Nakanishi, Yoko
    Iwai, Momoko
    Hirotani, Yukari
    Kato, Ren
    Tanino, Tomoyuki
    Nishimaki-watanabe, Haruna
    Nozaki, Fumi
    Ohni, Sumie
    Tang, Xiaoyan
    Masuda, Shinobu
    Sasaki-fukatsu, Kayoko
    THORACIC CANCER, 2023, 14 (27) : 2761 - 2769
  • [49] EXPRESSION AND CLINICAL SIGNIFICANCE OF CN- II IN NON-SMALL CELL LUNG CANCER TISSUES
    Qu, Li L.
    Liu, Qing X.
    Gao, Jun H.
    Qin, Feng H.
    Li, Jie J.
    Guo, Feng W.
    Wang, Xia W.
    Tang, Hao C.
    Li, Yan X.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S459 - S459
  • [50] Beta-2 microglobulin-free HLA class I heavy chain (FHC) A3 and/or A30 soluble products contribute only minimally to serum FHC expression
    Perosa, F
    Prete, M
    Luccarelli, G
    Favoino, B
    Dammacco, F
    EUROPEAN JOURNAL OF IMMUNOGENETICS, 2002, 29 (05): : 409 - 412
12345